ArticleCell death & disease2020

miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR.

Lin Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.